Clinical Trial Update: PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

An MD Anderson trial is evaluating PET/MRI, 18F-FDG PET/CT, and whole-body MRI to detect extramedullary myeloid leukemia in patients with newly diagnosed acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Promyelocytic Leukemia

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia, Acute Promyelocytic Leukemia With PML-RARA | Phase 1 | Status: RECRUITING